Affiliation:
1. Division of Interventional Neuroradiology Department of Radiological Sciences, and Section of Neuropathology
2. Department of Pathology and Laboratory Medicine and Brain Research Institute, University of California at Los Angeles School of Medicine, Los Angeles, California
Abstract
Abstract
OBJECTIVE
To report our experience in treatment of arteriovenous malformations (AVMs) using a new liquid embolic agent, Onyx (Micro Therapeutics, Inc., Irvine, CA).
METHODS
Between January 1998 and May 1999, 23 patients (8 men and 15 women) were treated. The patients' average age was 40 years, with seizure being the most common presenting symptom (39%). The average Spetzler-Martin grade on presentation was 3. The average AVM volume before embolization was 14.5 cm3.
RESULTS
We observed an average 63% reduction in AVM volume after 129 arterial feeders were embolized. There were four adverse events. Two patients experienced ischemia because of inadvertent occlusion of an arterial feeder. One of these patients made a full recovery, but the other patient had a permanent deficit. Two other patients experienced transient neurological deficits that resolved within 1 week of embolization. Permanent morbidity was thus 4% (1 of 23 patients). There were no deaths. Twelve patients underwent subsequent radiosurgery, and 11 patients had surgery that resulted in complete resection of their AVMs. Histopathological examinations showed mild acute inflammation in specimens resected 1 day after embolization. Chronic inflammatory changes were observed in specimens resected more than 4 days after embolization. In two patients, angionecrosis of the embolized vessels was noted. No evidence of parenchymal hemorrhage was observed in these patients, and vessel wall integrity was maintained as well.
CONCLUSION
Onyx is a new nonadhesive liquid embolic agent that has been used to treat 23 patients at our institution with good results. Its nonadhesive nature and ease of use make it a promising agent in the future treatment of AVMs.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Clinical Neurology,Surgery
Reference51 articles.
1. Cerebrovascular hemodynamics in arteriovenous malformation complicated by normal perfusion pressure breakthrough;Batjer;Neurosurgery,1988
2. Trisacryl gelatin microspheres for therapeutic embolization: Part II—Preliminary clinical evaluation in tumors and arteriovenous malformations;Beaujeux;AJNR Am J Neuroradiol,1996
3. Histopathologic and polymerization time studies;Brothers;AJNR Am J Neuroradiol,1989
4. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model;Chaloupka;AJNR Am J Neuroradiol,1999
5. Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model;Chaloupka;AJNR Am J Neuroradiol,1994
Cited by
250 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献